4-121340458-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198179.3(QRFPR):āc.493A>Gā(p.Met165Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000917 in 1,613,964 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00021 ( 1 hom., cov: 33)
Exomes š: 0.000079 ( 0 hom. )
Consequence
QRFPR
NM_198179.3 missense
NM_198179.3 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 3.82
Genes affected
QRFPR (HGNC:15565): (pyroglutamylated RFamide peptide receptor) Enables G protein-coupled receptor activity. Involved in G protein-coupled receptor signaling pathway. Predicted to be located in non-motile cilium. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.023628354).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
QRFPR | NM_198179.3 | c.493A>G | p.Met165Val | missense_variant | 2/6 | ENST00000394427.3 | NP_937822.2 | |
QRFPR | XM_017008693.3 | c.493A>G | p.Met165Val | missense_variant | 2/4 | XP_016864182.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
QRFPR | ENST00000394427.3 | c.493A>G | p.Met165Val | missense_variant | 2/6 | 1 | NM_198179.3 | ENSP00000377948.2 | ||
QRFPR | ENST00000512235.1 | n.905A>G | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
QRFPR | ENST00000334383.9 | c.493A>G | p.Met165Val | missense_variant | 2/6 | 2 | ENSP00000335610.5 | |||
QRFPR | ENST00000507331.5 | n.493A>G | non_coding_transcript_exon_variant | 2/7 | 2 | ENSP00000423369.1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152200Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
32
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251016Hom.: 0 AF XY: 0.000229 AC XY: 31AN XY: 135628
GnomAD3 exomes
AF:
AC:
54
AN:
251016
Hom.:
AF XY:
AC XY:
31
AN XY:
135628
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461646Hom.: 0 Cov.: 31 AF XY: 0.0000715 AC XY: 52AN XY: 727110
GnomAD4 exome
AF:
AC:
116
AN:
1461646
Hom.:
Cov.:
31
AF XY:
AC XY:
52
AN XY:
727110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000210 AC: 32AN: 152318Hom.: 1 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74490
GnomAD4 genome
AF:
AC:
32
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
17
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.493A>G (p.M165V) alteration is located in exon 2 (coding exon 2) of the QRFPR gene. This alteration results from a A to G substitution at nucleotide position 493, causing the methionine (M) at amino acid position 165 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;D
Sift4G
Benign
T;T
Polyphen
0.12
.;B
Vest4
MVP
MPC
0.70
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at